
Sergio Quezada
@squezadd
Follow the data trail
ID: 96841089
14-12-2009 21:07:56
140 Tweet
853 Followers
145 Following

We are hiring!! We are looking for talented postdocs experts in cancer immunology, molecular biology/antibody engineering to join Quezada Lab CRUKCOLcentre and the team that will make the next gen immune modulatory agents for cancer. ucl.ac.uk/work-at-ucl/se…




How the TCR transmits extracellular antigen binding into an intracellular signal remains enigmatic. In a collaborative project led by Ryan Notti, cryoEM of the TCR in its native environment reveals new mechanistic insight. Rockefeller University @MSKCC biorxiv.org/content/10.110…



Excited to present our first DECOD-Ag poster at CICON23! 🎉 Looking forward to sharing our research on predicting neoantigen immunogenicity and connecting with fellow attendees. #CICON23 #neoantigens Great collab with UCL, The Francis Crick Institute, DTU, Weizmann Institute and Achilles Therapeutics.

Really cool work to be presented by the Achilles Therapeutics team based on our collaboration with teams UCL Cancer Institute, yardena samuels Charles Swanton @Marcrmansour and the Hadrup Lab

Crispin Hiley presenting results from Darwin2 TRACERx prospective trial Clonal TMB associated with durable clinical benefit and transcriptomic intratumour heterogeneity with worse outcome Science and Innovation at Cancer Research UK UCL Cancer Institute The Francis Crick Institute CRUK Lung Centre


❕ Don't miss a new, very well-written Immunity review! Authors @EGhoranil, Sergio Quezada & Charles Swanton discuss cancer cell-intrinsic mechanisms driving acquired #ImmuneTolerance. 📘 shorturl.at/CMOPT



Dr Aurélien Marabelle Gustave Roussy announces Dr Steven A. Rosenberg recipient ESMO Immuno-Oncology Award! #ESMOimmuno23 ESMO - Eur. Oncology @NCI_CCR_SB @NCIResearchCtr @NCItreatment Dr. Kimryn Rathmell /notes Dr Eric Tran’s & Rom Leidner’s work Earle A. Chiles Research Institute of TCR KRAS #immunotherapy NEJM


⏰ Time for a review! Dr. Sergio Quezada and team discuss the current understanding of the contribution of FcγRs to the in vivo activity of immunomodulatory antibodies, and the challenges of translating results from preclinical models into the clinic. 🏥 go.nature.com/3Reej3D


UCL Cancer Institute UCL Faculty of Medical Sciences CRUK RadNet City of London Youtube link: youtu.be/-ymmHnPChiA?si…

Muchísimas gracias Martín De Ambrosio por esta editorial que me emocionó muchísimo. Gracias a tanta gente que ha trabajado y sigue apostando a que este sueño se haga realidad y permita dar muchísimas mas oportunidades, fundamentalmente a pacientes. lanacion.com.ar/sociedad/gabri…

Supernice paper on cis-targeted IL-2 therapy for chronic HBV from Iannacone Lab Science Translational Medicine!

Congratulations to Professors Christopher Denton @IIT_UCL, Alison Rodger UCL Global Health, @Mayor_lab @UCLBiosciences & @SQuezadd @UCLCancer on their election as Fellows to @AcMedSci in recognition of their outstanding contributions to biomedical research ucl.ac.uk/news/2024/may/…

Absolutely honoured to be elected Fellow of the Academy of Medical Sciences together with amazing UCL colleagues!! Thanks to UCL Cancer Institute Cancer Research UK and my amazing team Quezada Lab ucl.ac.uk/news/2024/may/…
